https://orcid.org/0000-0002-2522-2764
References
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020. DOI:10.1001/jama.2020.2648
- Cao B, Wang Y, Wen D, et al. A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020. DOI:10.1056/NEJMoa2001282
- Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020. DOI:10.1093/cid/ciaa237
- Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BST. 2020;14(1):72–73.
- Gautret P, Lagiera JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020. DOI:10.1016/j.ijantimicag.2020.105949
- Heavy. Chloroquine Phosphate: Arizona man dies after self-medicating. [Accessed 2020 Mar 22] https://heavy.com/news/2020/03/chloroquine-phosphate-death-dangerous-fish-cleaner/.
- Guillion C, Le Bonniec Y. Suicide mode d’emploi. Histoire, technique, actualite ́. Paris: Alan Moreau Editions; 1982.
- Legifrance. [Decision classifying hydrooxychloroquine in the list of poisonous substances]. JORF n°0012; 2020 Jan 15 [Accessed 2020 Mar 22]. https://beta.legifrance.gouv.fr/jorf/id/JORFTEXT000041400024.